Journal
CANCER
Volume 120, Issue 21, Pages 3268-3271Publisher
WILEY
DOI: 10.1002/cncr.28883
Keywords
-
Categories
Funding
- NCI NIH HHS [R21 CA164585, U54 CA132378, R21 CA164585-01A1, P50 CA086438, P50 CA086438-13, R21 CA164568-01A1, R21 CA164568, U54 CA137788] Funding Source: Medline
Ask authors/readers for more resources
Recent data indicate that chemotherapy treats cancer, at least in part, by facilitating an immune response to the tumor. The study results outlined in this issue highlight the potential benefits in devising an optimal strategy for integrating new immune-based therapies into the standard of care for various cancers.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
